Goldman Sachs’s Avadel Pharmaceuticals AVDL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.73M | Sell |
421,284
-306,585
| -42% | -$2.71M | ﹤0.01% | 3015 |
|
|
2025
Q1 | $5.7M | Sell |
727,869
-1,418,316
| -66% | -$11.1M | ﹤0.01% | 2653 |
|
|
2024
Q4 | $22.6M | Buy |
2,146,185
+286,217
| +15% | +$3.01M | ﹤0.01% | 1687 |
|
|
2024
Q3 | $24.4M | Buy |
+1,859,968
| New | +$24.4M | ﹤0.01% | 1587 |
|
|
2024
Q2 | – | Sell |
-374,203
| Closed | -$6.32M | – | 4733 |
|
|
2024
Q1 | $6.32M | Sell |
374,203
-113,048
| -23% | -$1.91M | ﹤0.01% | 2391 |
|
|
2023
Q4 | $6.88M | Buy |
487,251
+125,799
| +35% | +$1.78M | ﹤0.01% | 2359 |
|
|
2023
Q3 | $3.72M | Buy |
361,452
+148,653
| +70% | +$1.53M | ﹤0.01% | 2689 |
|
|
2023
Q2 | $3.51M | Buy |
212,799
+160,431
| +306% | +$2.64M | ﹤0.01% | 2822 |
|
|
2023
Q1 | $480K | Buy |
52,368
+24,050
| +85% | +$220K | ﹤0.01% | 4089 |
|
|
2022
Q4 | $203K | Sell |
28,318
-3,126
| -10% | -$22.4K | ﹤0.01% | 4497 |
|
|
2022
Q3 | $158K | Buy |
31,444
+10,646
| +51% | +$53.5K | ﹤0.01% | 4791 |
|
|
2022
Q2 | $51K | Sell |
20,798
-24,148
| -54% | -$59.2K | ﹤0.01% | 5273 |
|
|
2022
Q1 | $307K | Sell |
44,946
-12,057
| -21% | -$82.4K | ﹤0.01% | 4876 |
|
|
2021
Q4 | $461K | Buy |
57,003
+16,654
| +41% | +$135K | ﹤0.01% | 4574 |
|
|
2021
Q3 | $395K | Buy |
40,349
+5,834
| +17% | +$57.1K | ﹤0.01% | 4515 |
|
|
2021
Q2 | $232K | Buy |
34,515
+14,661
| +74% | +$98.5K | ﹤0.01% | 4849 |
|
|
2021
Q1 | $179K | Sell |
19,854
-55,521
| -74% | -$501K | ﹤0.01% | 4875 |
|
|
2020
Q4 | $504K | Buy |
75,375
+50,416
| +202% | +$337K | ﹤0.01% | 3817 |
|
|
2020
Q3 | $126K | Buy |
+24,959
| New | +$126K | ﹤0.01% | 4179 |
|
|
2020
Q2 | – | Sell |
-191,440
| Closed | -$1.52M | – | 4358 |
|
|
2020
Q1 | $1.52M | Buy |
+191,440
| New | +$1.52M | ﹤0.01% | 2902 |
|
|
2019
Q1 | – | Sell |
-16,000
| Closed | -$41K | – | 4162 |
|
|
2018
Q4 | $41K | Sell |
16,000
-4,877
| -23% | -$12.5K | ﹤0.01% | 3990 |
|
|
2018
Q3 | $92K | Sell |
20,877
-16,570
| -44% | -$73K | ﹤0.01% | 3965 |
|
|
2018
Q2 | $230K | Buy |
37,447
+10,937
| +41% | +$67.2K | ﹤0.01% | 3831 |
|
|
2018
Q1 | $193K | Buy |
26,510
+212
| +0.8% | +$1.54K | ﹤0.01% | 3868 |
|
|
2017
Q4 | $216K | Sell |
26,298
-8,861
| -25% | -$72.8K | ﹤0.01% | 3799 |
|
|
2017
Q3 | $369K | Buy |
35,159
+1,888
| +6% | +$19.8K | ﹤0.01% | 3641 |
|
|
2017
Q2 | $367K | Sell |
33,271
-43,667
| -57% | -$482K | ﹤0.01% | 3692 |
|
|
2017
Q1 | $745K | Sell |
76,938
-3,996
| -5% | -$38.7K | ﹤0.01% | 3278 |
|
|
2016
Q4 | $841K | Buy |
80,934
+49,308
| +156% | +$512K | ﹤0.01% | 3173 |
|
|
2016
Q3 | $392K | Buy |
31,626
+9,630
| +44% | +$119K | ﹤0.01% | 3568 |
|
|
2016
Q2 | $236K | Buy |
21,996
+6,996
| +47% | +$75.1K | ﹤0.01% | 3766 |
|
|
2016
Q1 | $166K | Buy |
+15,000
| New | +$166K | ﹤0.01% | 3859 |
|